Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Under Armour Inc Class A (UAA) Price & Performance

Novartis AGTrade
Under Armour Inc Class ATrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Under Armour Inc Class A — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Under Armour Inc Class A trades at $7.3 (market cap $3.07B). The key difference: Novartis AG is far larger — about 94.5× Under Armour Inc Class A's market cap, and Novartis AG pays a 3.17% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.

NVSUAA
Market Cap
$290.25B$3.07B
Sector
HealthConsumer Cyclical
52-Week High
$168.62$8.14
52-Week Low
$113.50$4.17
Enterprise Value
$330.27B$4.70B
Dividend Yield
3.17%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Under Armour Inc Class A

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.

Read more on UAA